SaMD Registration in the US

Quick Snapshot

Service: AI-SaMD Registration with U.S. FDA
Who Can Apply:
- Software developers
- Medical device manufacturers
- Digital health companies
- U.S. or foreign manufacturers
Timeline: Depends on the regulatory pathway, device classification, and FDA review timelines.
Deliverables:
- Regulatory Applicability Assessment
- FDA Regulatory Pathway Determination
- Technical Documentation Review
- Clinical & Performance Evidence Assessment
- FDA Submission Support
- Regulatory Query Management
Purpose: Support AI-SaMD manufacturers in determining the appropriate FDA regulatory pathway, preparing compliant documentation, and achieving successful market authorization.

What is AI-SaMD Registration?

Artificial Intelligence Software as a Medical Device (AI-SaMD) refers to software that utilizes Artificial Intelligence (AI) or Machine Learning (ML) technologies to perform one or more medical functions. These solutions may support diagnosis, disease detection, clinical decision-making, patient monitoring, treatment planning, medical image analysis, and other healthcare applications.

In the United States, AI-SaMD products are regulated by the U.S. Food and Drug Administration (FDA) under the medical device regulatory framework. Depending on the intended use, risk level, and technological characteristics of the software, manufacturers may be required to obtain FDA clearance, approval, or authorization before commercial distribution.

FDA compliance helps demonstrate that AI-enabled healthcare software is safe, effective, reliable, and supported by appropriate evidence, enabling successful market access in one of the world's largest healthcare markets.

When Do You Need AI-SaMD Registration?

FDA regulatory requirements may apply if your AI-enabled software is intended for medical purposes such as:

When Do You Need AI-SaMD Registration?

AI-powered diagnostic software
Clinical Decision Support Systems (CDSS)
Medical image analysis and interpretation software
Disease prediction and risk assessment tools
Patient monitoring and remote monitoring applications
Digital therapeutics incorporating AI technologies
Radiology and pathology AI solutions

Key Challenges

Predictive healthcare analytics platforms
Treatment recommendation software
Software used to support clinical decision-making
Determining whether the software qualifies as a medical device
Identifying the appropriate FDA regulatory pathway
Understanding FDA expectations for AI/ML-enabled software
Demonstrating safety, effectiveness, and clinical performance

Our Approach and What You Will Get

At Tacit Medtek, we provide comprehensive support throughout the FDA regulatory process for AI-SaMD products.

Our Approach

Regulatory Assessment
Regulatory Pathway Determination
Gap Assessment and Regulatory Strategy
Clinical and Performance Evidence Review
Software Documentation and Compliance Review
FDA Submission Support
Regulatory Query Management

What You Will Get (Deliverables)

Regulatory applicability assessment
FDA pathway determination
Regulatory strategy roadmap
Gap assessment report
Technical documentation review
Clinical evidence assessment
Software validation review
Risk management review

Why Choose Tacit Medtek and Case Example

Practical FDA regulatory support for medical device and AI-enabled healthcare companies.

Why Choose Tacit Medtek

Expertise in FDA medical device regulations
Experience supporting AI-enabled healthcare technologies
Strong understanding of AI/ML regulatory expectations
Practical and risk-based regulatory strategies
Structured documentation support
End-to-end assistance throughout the regulatory process
Dedicated support for submissions and compliance activities
Focus on efficient and successful market access

Case Example

Challenge: A digital health company developed an AI-powered radiology software solution designed to assist clinicians in detecting abnormalities from medical images. The company required guidance on FDA regulatory requirements and the most appropriate submission pathway.
Our Approach: Tacit Medtek conducted a regulatory assessment, identified the applicable FDA pathway, reviewed software documentation, evaluated performance evidence, and supported submission planning activities.
Outcome: The client established a clear regulatory strategy, strengthened its documentation package, and successfully progressed toward FDA market authorization.

FAQ

Frequently Asked Questions

How does the FDA classify AI-SaMD products?

AI-SaMD products are generally classified as Class I, Class II, or Class III devices based on risk and intended use.

What FDA pathways are available for AI-SaMD?

Depending on the product, manufacturers may pursue a 510(k), De Novo Request, or Premarket Approval (PMA) pathway.

What evidence is required for FDA submissions?

Manufacturers may need to provide software validation data, performance testing, risk management documentation, cybersecurity information, and clinical evidence where applicable.

Can Machine Learning algorithms continue to learn after deployment?

Yes. Certain Machine Learning algorithms may continue to learn or be updated after deployment. However, manufacturers should establish appropriate controls and change management processes for software modifications and algorithm updates that may impact device performance.

Is cybersecurity important for AI-SaMD compliance?

Yes. Cybersecurity is a key consideration for software-based medical devices and should be addressed throughout the product lifecycle.

Get In Touch

Enquire Now

Send Enquiry

Fill in the form and our team will get back to you shortly.

Full Name

Phone

Email Address

Company Name

Subject

Type your Message...

Your information is secure and will never be shared.

Need Help?

Reach our regulatory experts directly.

+91 9409299368 Call Us

contact@tacitmedtek.com Email Us

bd@tacitmedtek.com Email Us